New $25 Million Accelerator Bets On Better Model For Rare Disease

Rare disease, epidermolysis bullosa, venture philanthropy,

Insurer Denials High In Medicare Advantage, Medicaid And Obamacare, Report Says

Health insurers denied “at least 1 in 8 standard requests” when prior authorization was required across Medicare Advantage, Medicaid and Obamacare last year, KFF said.

Improving Diabetes Treatment Through RNA Technology

A targeted RNA therapy boosts VEGF‑A in transplanted beta cells, accelerating blood-vessel growth and improving islet survival and glucose control for Type 1 diabetes.

How Some Rural Communities Maintain Access To Labor And Delivery

Rural obstetric units have been closing at an alarming rate across the country. Some hospitals model how to overcome financial and staffing constraints, as shown here.

Doctors Push Back Against Trump’s Vaccine Order

In this week’s edition of InnovationRx, we look at the potential impact of Trump’s executive order on vaccines, the healthcare dynamos on Forbes 50 Over 50, a Swiss startup focused on a rare bleeding disorder, and more.

Targeting Cancer’s Weak Spot

New antibodies recognize mutant KRAS fragments displayed on tumor cells, unlocking a way to target pancreatic, colorectal, and lung cancers.

Trump Issues Executive Order On Vaccines, Makes Multiple False Claims

Trump signed an executive order to reshape the childhood vaccine schedule. He made multiple false claims, including repeating the debunked vaccines and autism link.

Congo’s Ebola Epidemic Began With A Fresh Jump From An Animal. Dating It Will Take More Genomes

The first genomes from Congo’s Bundibugyo Ebola outbreak point to a recent animal spillover, but are too few to date when the jump happened.

Bitter Lessons From The EMR For The AI Experiment

The digitization of medical records, mandated by the HITECH Act of 2009, achieved near-universal adoption but brought substantial unintended consequences.

Sick Kids, Stalled Science: America’s Pediatric Health Funding Crisis

Pediatric health is critically underfunded, despite 1/3 of the global population being kids. But the ROI of investing in kids yields profound health and economic returns.